NDC 0406-5116 – Lisdexamfetamine Dimesylate

Lisdexamfetamine Dimesylate 60 mg/1 · Capsule · Oral

Human Prescription Drug DEA schedule CII

Product NDC0406-5116

Product details

Brand name
Lisdexamfetamine Dimesylate
Generic name
Lisdexamfetamine Dimesylate
Labeler
SpecGx LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA211840
Marketed since
August 25, 2023
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Lisdexamfetamine dimesylate →

Package NDC codes (1)

Package NDCDescriptionSince
0406-5116-01100 CAPSULE in 1 BOTTLE (0406-5116-01)Aug 25, 2023

Other Lisdexamfetamine dimesylate products